Drug intelligence / Profile preview

Poliflav M.A.

Development stage
Unknown
Lead developer
Logofarma
Modality
Small Molecules
Administration
Oral
01

Overview

Poliflav M.A. is a multi-ingredient vascular support formulation, typically classified as a dietary supplement or nutraceutical, primarily utilized in the management of chronic venous insufficiency and microcirculatory disorders. Its core composition includes a combination of bioflavonoids: diosmin, troxerutin, and hesperidin. The therapeutic effect is achieved through phlebotonic and vasoprotective actions. Diosmin increases venous tone by inhibiting catechol-O-methyltransferase (COMT), which leads to prolonged activity of norepinephrine on the venous wall. Troxerutin and hesperidin contribute by reducing capillary hyper-permeability and providing anti-inflammatory effects through the inhibition of pro-inflammatory mediators and the expression of adhesion molecules. The product is frequently indicated for conditions such as varicose veins, hemorrhoidal disease, and capillary fragility, and it is largely associated with the Italian pharmaceutical market.

Brand names
Poliflav M.A.
Other names
Poliflav MA
02

Targets

COMT (Catechol-O-methyltransferase)VCAM1 (Vascular cell adhesion molecule 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)ICAM1 (Intercellular Adhesion Molecule 1)

Beyond the preview

Go deeper on Poliflav M.A..

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Poliflav M.A..

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call